MELISI, Davide

MELISI, Davide  

DIPARTIMENTO DI MEDICINA  

Mostra records
Risultati 1 - 20 di 133 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autore(i) File
A novel modified CpG agonist of TLR-9 inhibits EGF receptor signalling and synergistically enhances antitumor activity of cetuximab and irinotecan eradicating colon cancer xenografts 1-gen-2005 Tortora, Giampaolo; Bianco, R.; Caputo, R.; D'Armiento, F.; Melisi, Davide; Bianco, A. R.; De Placido, S.; Agrawal, S.; Ciardiello, F.; Damiano, V.
A novel modified CpG inhibits EGF receptor signalling and synergistically enhances antitumor activity of cetuximab and irinotecan in colon cancer xenografts. 1-gen-2005 Tortora, Giampaolo; Bianco, R.; Caputo, R.; D'Armiento, F.; Melisi, Davide; Bianco, A. R.; De Placido, S.; Agrawal, S.; Ciardiello, F.; Damiano, V.
A selective cyclooxygenase-2 inhibitor combined with the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') and protein kinase A antisense causes cooperative tumor growth inhibition after oral administration 1-gen-2002 Tortora, Giampaolo; Caputo, R.; Damiano, V.; Melisi, Davide; Bianco, R.; Fontanini, G.; Bianco, A. R.; Ciardiello, F.
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 1-gen-2018 Carbone, C; Piro, G; Gaianigo, Nicola; Ligorio, F; Santoro, R; Merz, V; Simionato, F; Zecchetto, C; Falco, G; Conti, G; Kamga, P. T; Krampera, M; Di Nicolantonio, F; De Franceschi, L; Scarpa, A; Tortora, G; Melisi, D.
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data 1-gen-2019 Marchegiani, Giovanni; Andrianello, Stefano; Dal Borgo, Chiara; Secchettin, Erica; Melisi, Davide; Malleo, Giuseppe; Bassi, Claudio; Salvia, Roberto
AGENTI BIOLOGICI e CHEMIOTERAPICI: INTEGRAZIONE 1-gen-2005 Tortora, Giampaolo; Melisi, Davide
Angiogenesis: A target for cancer therapy. 1-gen-2004 Tortora, Giampaolo; Melisi, Davide; Ciardiello, F.
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 1-gen-2015 Carbone, C; Piro, G; Fassan, Matteo; Tamburrino, A; Mina, Maria Mihaela; Zanotto, M; Chiao, Pj; Bassi, Claudio; Scarpa, Aldo; Tortora, Giampaolo; Melisi, Davide
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 1-gen-2018 Carbone, Carmine; Piro, Geny; Merz, Valeria; Simionato, Francesca; Santoro, Raffaela; Zecchetto, Camilla; Tortora, Giampaolo; Melisi, Davide
Anti- VEGF treatment resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype 1-gen-2011 Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide
Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. 1-gen-2011 Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. 1-gen-2004 Raben, D; Bianco, C; Damiano, V; Bianco, R; Melisi, Davide; Mignogna, C; Darmiento, Fp; Cionini, L; Bianco, Ar; Tortora, Giampaolo; Ciardiello, F; Bunn, P.
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. 1-gen-2004 D., Raben; C., Bianco; V., Damiano; R., Bianco; Melisi, Davide; C., Mignogna; F. P., D'Armiento; L., Cionini; A. R., Bianco; Tortora, Giampaolo; F., Ciardiello; P., Bunn
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. 1-gen-2004 Ciardiello, F; Bianco, R; Caputo, R; Caputo, R; Damiano, V; Troiani, T; Melisi, Davide; DE VITA, F; S., DE PLACIDO; Bianco, Ar; Tortora, Giampaolo
Antitumor efficacy of the novel poly(ADP-ribose) polymerase (PARP-1) inhibitor BSI-401 and synergism with oxaliplatin (OX) in an orthotopic murine model of pancreatic cancer (PC) 1-gen-2009 Melisi, Davide; Ossovskaya, V.; Sherman, B. M.; Abbruzzese, J. L.; Chiao, P. J.
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer 1-gen-2017 Humphries, Matthew P; Sundara Rajan, Sreekumar; Droop, Alastair; Suleman, Charlotte A. B; Carbone, Carmine; Nilsson, Cecilia; Honarpisheh, Hedieh; Cserni, Gabor; Dent, Jo; Fulford, Laura; Jordan, Lee B; Jones, J. Louise; Kanthan, Rani; Litwiniuk, Maria; Di Benedetto, Anna; Mottolese, Marcella; Provenzano, Elena; Shousha, Sami; Stephens, Mark; Walker, Rosemary A; Kulka, Janina; Ellis, Ian O; Jeffery, Margaret; Thygesen, Helene H; Cappelletti, Vera; Daidone, Maria G; Hedenfalk, Ingrid A; Fjällskog, Marie Louise; Melisi, Davide; Stead, Lucy F; Shaaban, Abeer M; Speirs, Valerie
Chart review of diagnostic methods, baseline characteristics and symptoms for European patients with pancreatic cancer 1-gen-2021 Carrato, A; Melisi, D; Prager, G; Westphalen, Cb; Ferreras, A; D'Esquermes, N; Taieb, J; Mercade, Tm
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 1-gen-2017 Piro, Geny; Simionato, Francesca; Carbone, Carmine; Frizziero, Melissa; Malleo, Giuseppe; Zanini, SILVIA MARIA; Casolino, Raffaella; Santoro, Raffaela; Mina, Maria Mihaela; Zecchetto, Camilla; Merz, Valeria; Scarpa, Aldo; Bassi, Claudio; Tortora, Giampaolo; Melisi, Davide
Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib 1-gen-2021 Silverman, Ian M; Hollebecque, Antoine; Friboulet, Luc; Owens, Sherry; Newton, Robert C; Zhen, Huiling; Féliz, Luis; Zecchetto, Camilla; Melisi, Davide; Burn, Timothy C
Combination of a selective cyclooxygenase-2 inhibitor with EGFR tyrosine kinase inhibitor ZD1839 (‘Iressa’) and Protein Kinase A antisense causes a cooperative antitumor and antiangiogenic effect 1-gen-2003 Tortora, Giampaolo; Caputo, R; Damiano, V; Caputo, R; Melisi, Davide; Bianco, R; Fontanini, G; Veneziani, Bm; DE PLACIDO, S; Bianco, Ar; Ciardiello, F.